Home Cart Sign in  
Chemical Structure| 402473-54-5 Chemical Structure| 402473-54-5

Structure of ONO-AE3-208
CAS No.: 402473-54-5

Chemical Structure| 402473-54-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ONO-AE3-208 is an antagonist of EP4 with Ki of 1.3 nM and exhibits suppression the invasion and metastasis of prostate cancer cells.

Synonyms: AE 3-208

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ONO-AE3-208

CAS No. :402473-54-5
Formula : C24H21FN2O3
M.W : 404.43
SMILES Code : O=C(O)CCCC1=CC=C(C#N)C=C1NC(C(C2=C3C=CC=CC3=C(F)C=C2)C)=O
Synonyms :
AE 3-208
MDL No. :MFCD13184814
InChI Key :MTDIMKNAJUQTIO-UHFFFAOYSA-N
Pubchem ID :10111831

Safety of ONO-AE3-208

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P280

Related Pathways of ONO-AE3-208

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human primary colon carcinoma cells 10μM 3 weeks Reduced PGE2-induced CSCs formation and expansion PMC4762503
LS-174T cells 10μM 3 weeks Reduced PGE2-induced CSCs formation and expansion PMC4762503

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Experimental autoimmune encephalomyelitis (EAE) model Oral 10 mg/kg Once daily, from day -1 to day 25, or from day -1 to day 7, or from day 7 to day 25 To investigate the effects of ONO-AE3-208 in the EAE model, it was found that the drug significantly suppressed EAE signs during the immunization phase but had only a mild suppressive effect on the peak of the disease when administered throughout the experimental period (from day -1 to day 25), suggesting that EP4 signaling has a facilitative role in the immunization phase and a preventive role in the elicitation phase. PMC2901475

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.47mL

0.49mL

0.25mL

12.36mL

2.47mL

1.24mL

24.73mL

4.95mL

2.47mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories